(R)-tert-Butyl (1-(pyrrolidin-3-yl)cyclopropyl)carbamate

Catalog No.: 
ACSCXZ435
CAS No.: 
431058-52-5
Molecular Formula: 
C12H22N2O2
Molecular Weight: 
226.32
(R)-tert-Butyl (1-(pyrrolidin-3-yl)cyclopropyl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$367.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(R)-tert-Butyl (1-(pyrrolidin-3-yl)cyclopropyl)carbamate
IUPAC Nametert-butyl (R)-(1-(pyrrolidin-3-yl)cyclopropyl)carbamate
MDL No.MFCD27922176
Molecular FormulaC12H22N2O2
Molecular Weight226.32
SMILESO=C(OC(C)(C)C)NC1([C@H]2CNCC2)CC1
InChI KeyQJTCVIHNVLALCL-SECBINFHSA-N
Synonym(R)-TERT-BUTYL (1-(PYRROLIDIN-3-YL)CYCLOPROPYL)CARBAMATE;Carbamic acid, [1-(3R)-3-pyrrolidinylcyclopropyl]-, 1,1-dimethylethylester;Carbamic acid, N-[1-(3R)-3-pyrrolidinylcyclopropyl]-, 1,1-dimethylethyl ester;tert-Butyl(R)-(1-(pyrrolidin-3-yl)cyclopropyl)carbamate;(R)-N-Boc-1-(3-pyrrolidinyl)cyclopropanamine
CAS No.431058-52-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACSCXZ435 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSCXZ435 route product structure diagram
    ACSCXZ435431058-52-5
Inquiry

2. ACSCXZ435 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSCXZ435 route product structure diagram
    ACSCXZ435431058-52-5
Inquiry

3. ACSCXZ435 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSCXZ435 route product structure diagram
    ACSCXZ435431058-52-5
Inquiry

Comments (0)